Researchers to test methods for helping smokers quit

Experts say cigarette price increases may boost desire to quit

With large price jumps in the cost of cigarettes and the New Year fast approaching, many smokers may be even more highly motivated to quit the habit. The UW Medical School is launching two large new studies aimed particularly at those who have tried — and perhaps tried again — to quit.

The studies will assess two different medications, both of which are being tested for the first time for their effectiveness in helping people quit smoking.

“These studies are open to any smokers between the ages of 18 and 65, provided they are not ruled out due to certain medical conditions,” said Dr. Michael Fiore, head of the Center for Tobacco Research and Intervention at UW Medical School. “But they may be of particular interest to people who have made earlier, unsuccessful attempts to quit. Both of these medications are new approaches to smoking cessation and we are most interested to see if they can be added to the tools available for those seeking to quit.”

Those participating will be randomly assigned to one of various groups receiving the medication, a placebo, or an existing smoking cessation aid. To ensure the validity of the results, neither the researchers nor the participants will know which agent they are using. All participants, however, will receive free counseling as an integral part of the research project design.

The studies begin in early January and will last up to one year. However, potential participants need to register by Dec. 11. The counseling and treatment will occur at University of Wisconsin Hospital and Clinics, 600 Highland Ave., Madison and at UW Medical School, 1300 University Ave. For more information about the studies, contact the Center for Tobacco Research and Intervention at (608) 265-2430.